Researchers have discovered that compounds altering transmembrane potential in Xenopus laevis may improve resistance to E. coli infection.
Browsing: Disease Area > Bacterial
Helen McShane discusses her work leading the TB vaccine research program at Oxford University, and shares her thoughts on the challenges facing vaccine development and eradication of this disease.
The lack of viable antibiotics has urged researchers to think of new approaches to treat deadly bacterial infections. This editorial discusses the progress so far, and the future applications, of strategies involving predatory bacteria.
Antivirulence agents represent an attractive alternative to antibiotics. Here, the authors discuss the advantages, and the gaps in antivirulence therapy.
New research has investigated the burden of nontuberculosis mycobacterium pulmonary disease in Germany, discovering high mortality and financial burden.
A novel type of wound dressing that combines both hydrogel dressings and chitosan could reduce the risk of bacterial infection in recovering patients.
A novel, bioinspired antimicrobial treatment, consisting of iodo-thiocyanate complexes, has demonstrated promising results as a bactericidal compound, according to new research.
In this editorial the authors offer a perspective about issues surrounding the implementation of molecular antibiograms in the diagnostic workflow.
Researchers have utilized CRISPR/Cas9 technology on human induced pluripotent stem cells to identify genes involved in fighting off Chlamydia trachomatis infections.